Health Condition 1: F330- Major depressive disorder, recurrent, mild Health Condition 2: F331- Major depressive disorder, recurrent, moderate
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants showing signs of Mild to Moderate Depression as per DSM-V Criteria. (PHQ-9 score 5-14). Participants providing written informed consent of caretakers/parents. Participants providing written informed assent to participate in the study.
Exclusion criteria
Exclusion criteria: No Depression (PHQ- 9 score below or equals to 4) along with no other clinical manifestation. Severe Depression (PHQ- 9 score equal or above 15). Intelligent Quotient (IQ) Below 70 [Borderline Intelligence]. Any severe co-morbid psychiatric disorder, especially a diagnosis of bipolar disorder, schizophrenia, autism spectrum disorder, schizoaffective disorder or organic psychiatric disorder assessed by taking detailed history and examination. Any other medical or neurological conditions or any other illness interfering with interventions. Participants suffering from any systemic illness, history of epilepsy or chronic illness like hypo or hyperthyroidism. Substance use disorder or dependency, suicidal ideations. Current use of Anti-epileptics, anti-psychotic or psychotropic drugs (e.g., Selective Serotonin Reuptake Inhibitor, Serotonin and norepinephrine reuptake inhibitors etc.) and any other investigational drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in the PHQ-9 score.Timepoint: Before Treatment-After Treatment (8weeks) | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in sleep quality of adolescents. Improvement in Clinical Global Impression Score. Improvement in the quality of life (QOL)Timepoint: Before Treatment-After Treatment (8weeks) | — |
Countries
India
Contacts
All India Institute of Ayurveda (AIIA)